Literature DB >> 8707497

Beware of surrogate outcome measures.

P C Gøtzsche1, A Liberati, V Torri, L Rossetti.   

Abstract

Surrogate outcome measures may speed up clinical research if they can be measured earlier in a study than the primary outcome of interest. We review the justification for their use and conclude that reliance on them may be harmful. Results obtained with surrogates should therefore be regarded as preliminary. Large, definitive trials with clinically relevant outcomes should always be performed before new interventions are accepted.

Mesh:

Year:  1996        PMID: 8707497     DOI: 10.1017/s0266462300009594

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

Review 2.  Getting research findings into practice. When to act on the evidence.

Authors:  T A Sheldon; G H Guyatt; A Haines
Journal:  BMJ       Date:  1998-07-11

Review 3.  Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.

Authors:  Peter C Gøtzsche; Helle Krogh Johansen
Journal:  Cochrane Database Syst Rev       Date:  2016-09-20

Review 4.  [Patient-reported and patient-weighted outcomes in ophthalmology].

Authors:  F Scheibler; R P Finger; R Grosselfinger; C-M Dintsios
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

5.  Redactions in protocols for drug trials: what industry sponsors concealed.

Authors:  Mikkel Marquardsen; Michelle Ogden; Peter C Gøtzsche
Journal:  J R Soc Med       Date:  2018-01-25       Impact factor: 5.344

Review 6.  Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study.

Authors:  Jeppe Lerche la Cour; Jesper Brok; Peter C Gøtzsche
Journal:  BMJ       Date:  2010-08-18

7.  The role of cognition in cost-effectiveness analyses of behavioral interventions.

Authors:  Rilana Prenger; Louise M Braakman-Jansen; Marcel E Pieterse; Job van der Palen; Erwin R Seydel
Journal:  Cost Eff Resour Alloc       Date:  2012-03-01

8.  Patients not patents: Drug research and development as a public enterprise.

Authors:  Peter C Gøtzsche
Journal:  Eur J Clin Invest       Date:  2018-01-05       Impact factor: 4.686

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.